Seven Eight Capital, LP Cooper Companies, Inc. Transaction History

Seven Eight Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$263.81 - $337.27 $259,852 - $332,210	985 New	985 $260,000
Q3 2020 Nov 16, 2020	SELL	$280.08 - $347.78 $420,120 - $521,669	-1,500 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$270.93 - $320.3 $406,395 - $480,450	1,500 New	1,500 $425,000
Q1 2018 May 14, 2018	SELL	$218.74 - $251.43 $371,858 - $427,431	-1,700 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$217.88 - $244.43 $370,396 - $415,531	1,700 New	1,700 $370,000
Q3 2017 Oct 16, 2017	SELL	$231.6 - $253.39 $810,600 - $886,865	-3,500 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	3,500	3,500 $838,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.